PRKAG2 and Danon disease: Promising pre-clinical studies show that glycogen-storage cardiomyopathy and conduction system degeneration associated with PRKAG2 mutation might be reversible, and the development of accessory pathways may be prevented by inhibition of glycogen accumulation during early postnatal development [81].